Planning Medical Abstracts and Manuscripts

Planning Medical Abstracts and Manuscripts

$1,995.00

Medical Affairs Product Launch Series (Module 2.5)

This module showcases innovations at medical publications teams.  Highlights include medical publications staffing and budget allocation, as well as benchmarks on medical abstracts and manuscripts, during the launch window.

Publication Date: June 2018
Pages: 62
Figures: 35+

To learn more about the other modules in the Medical Affairs Product Launch Series and the benefits of subscribing to the entire series, click here.

  • Description
  • Additional information

Planning Medical Abstracts and Manuscripts

Planning Medical Abstracts and Manuscripts is the fifth module of the 10-part Medical Affairs Product Launch Series.  This module outlines medical publications teams' budgets, staffing and activity levels throughout the launch window. In so doing, it also shines a light on planning medical abstracts and manuscripts as products progress through the lifecycle.  For example, during product launch year, surveyed teams publish anywhere between 2 and 40 medical abstracts.  They also publish between 0 and 10 manuscripts during product launch year.

The benchmarks, including key performance indicators, and profiles will help your medical publications team to:

  • Compare how pharmaceutical and device organizations allocate medical publications resources in the years immediately surrounding product launch, by organization size, geographic location and product type. These benchmarks will allow you to improve your team’s ability for planning medical abstracts and manuscripts. Align your company’s resources with your publications team’s anticipated output.
  • Develop best practices to facilitate planning medical abstracts and manuscripts. Avoiding unnecessary or redundant publications will strengthen overall medical communication with healthcare audiences.
  • Evaluate how resource levels and activity levels shift and interact throughout the product launch window at individual life science teams.

In developing this module, Cutting Edge Information’s analysts collected surveys from and consulted with a series of medical affairs leaders at several top pharmaceutical, biotechnology and medical device companies.  This edition expands on last year’s medical affairs product launch series with additional data across all product types and new publications team profiles.

To learn more about the other modules in the Medical Affairs Product Launch Series and the benefits of subscribing to the entire series, click here.

Report Features

Discover best practices for medical publications strategy, as shared by top medical affairs executives across the life sciences industry.
-Examine benchmarks for medical publications team resources and activities and use these to guide your team resources throughout the launch window. Throughout the module, data are broken down by team region and product type.
-Use key performance indicators (KPIs) to gauge planning annual medical abstracts and manuscripts’ publication levels.
-Study 10 profiles that illustrate individual real-world publications teams’ approaches for planning medical abstracts and manuscripts. See how these groups allocate their budgets, staffing, medical abstracts and manuscripts across product development stages.

Reasons to Buy

Benchmark your team’s medical publications resources in the years immediately surrounding product launch. Determining the number of publications activities necessary to support a new product depends on many factors, including team region, product type and lifecycle.  Use the benchmarks in this module to align your company’s resources with anticipated medical abstracts and manuscripts activity levels throughout the launch window.

Evaluate case studies of individual medical publications teams to defend or justify your team’s needs. Surveyed medical affairs teams’ resources and KPIs change throughout the launch window. Through detailed profiles, this research study examines the allocation of medical publications staffing, budgets, abstracts and manuscripts among surveyed teams throughout the launch window.

Target Audience

Pharmaceutical, biotechnology and medical device executives in the following departments will find the best practices and benchmarks in this study most useful when making strategic decisions:
– Medical publications
– Medical information
– Medical communications
– Medical affairs
– Medical education
– Medical writing
– Clinical development

Chapter Example

Emphasize Publication Quality Before Quantity

Another concern for surveyed teams is publication quality. Pharmaceutical and device companies can struggle to achieve high-quality publications for two primary reasons. First, in their efforts to disseminate research findings across multiple healthcare audiences, they may prioritize quantity of publications above publication quality. Doing so could dilute the value of the medical findings companies are trying to emphasize. Second, surveyed teams that do not adopt a scientific voice when compiling publications risk rejection from top-tier journals. Journal review committees may reject publication submissions they perceive as overly commercial.

In a Company C VP’s experience, teams sometimes “split the data 14 different ways until Sunday” and aim for publications across 29 obscure journals. Instead, he advises teams — particularly those at small pharmaceutical organizations — to focus on a limited number of high-tier journals. This executive believes that medical findings are strongest when they are concentrated in a few well-respected journals, rather than spread across larger numbers of lower-tier publications.